Correlation Between Oric Pharmaceuticals and Amicus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Amicus Therapeutics, you can compare the effects of market volatilities on Oric Pharmaceuticals and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Amicus Therapeutics.

Diversification Opportunities for Oric Pharmaceuticals and Amicus Therapeutics

0.07

Correlation Coefficient

Oric Pharmaceuticals  Amicus Therapeutics

Significant diversification

The 3 months correlation between Oric and Amicus is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Amicus Therapeutics go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Amicus Therapeutics

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 2.15 times more return on investment than Amicus Therapeutics. However, Oric Pharmaceuticals is 2.15 times more volatile than Amicus Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.32 per unit of risk. If you would invest  938.00  in Oric Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  52.00  from holding Oric Pharmaceuticals or generate 5.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Amicus Therapeutics

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Oric Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Amicus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Oric Pharmaceuticals and Amicus Therapeutics

The main advantage of trading using opposite Oric Pharmaceuticals and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.

The idea behind Oric Pharmaceuticals and Amicus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.